Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension
被引:33
|
作者:
Minami, J
论文数: 0引用数: 0
h-index: 0
机构:
Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, JapanDokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
Minami, J
[1
]
Kawano, Y
论文数: 0引用数: 0
h-index: 0
机构:Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
Kawano, Y
Makino, Y
论文数: 0引用数: 0
h-index: 0
机构:Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
Makino, Y
Matsuoka, H
论文数: 0引用数: 0
h-index: 0
机构:Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
Matsuoka, H
Takishita, S
论文数: 0引用数: 0
h-index: 0
机构:Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
Takishita, S
机构:
[1] Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
[2] Natl Cardiovasc Ctr, Div Nephrol & Hypertens, Osaka 5650873, Japan
Aims The aim of the present study was to evaluate the effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Methods Ten inpatients with mild to moderate essential hypertension (four men and six women; age: 44-64 years) underwent a drug-free period for 7 days and a treatment period with cilnidipine 10 mg orally for another 7 days, in a randomized crossover study. On the sixth day of each period, they underwent autonomic function tests including a mental arithmetic test, a cold presser test and a Valsalva manoeuvre. After these tests, 24 h ambulatory blood pressure, heart rate, and the electrocardiogram R-R intervals were monitored every 30 min. A power spectral analysis of R-R intervals was performed to obtain the low-and high-frequency components. Results Cilnidipine significantly decreased the 24 h blood pressure by 6.5 +/- 1.7 mm Hg systolic (mean+/-s.e.mean; P<0.01) and 5.0+/-1.1 mmHg diastolic (P<0.01), whereas cilnidipine did not change heart rate or any indices of power spectral components. During the cold presser test, the maximum change in systolic blood pressure and percentage changes in both systolic and diastolic blood pressures were significantly lower during the treatment period with cilnidipine than during the drug-free period. The baroreflex sensitivity measured from the overshoot phase of the Valsalva manoeuvre did not differ significantly between the two periods. Conclusions Cilnidipine is effective as a once-daily antihypertensive agent and causes little influence on heart rate and the autonomic nervous system in patients with mild to moderate essential hypertension. Moreover, it is suggested that cilnidipine has an additional clinical benefit in the inhibition of the presser response induced by acute cold stress.
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Abe, Hiroko
论文数: 引用数:
h-index:
机构:
Mita, Tomoya
Yamamoto, Risako
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Yamamoto, Risako
Komiya, Koji
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Komiya, Koji
Kawaguchi, Minako
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Kawaguchi, Minako
Sakurai, Yuko
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Sakurai, Yuko
Shimizu, Tomoaki
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Shimizu, Tomoaki
Ohmura, Chie
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Ohmura, Chie
Ikeda, Fuki
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Ikeda, Fuki
Kawamori, Ryuzo
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Kawamori, Ryuzo
Fujitani, Yoshio
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Juntendo Univ, Grad Sch Med, Ctr Beta Cell Biol & Regenerat, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Fujitani, Yoshio
Watada, Hirotaka
论文数: 0引用数: 0
h-index: 0
机构:
Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo, Japan
Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan
Juntendo Univ, Grad Sch Med, Ctr Beta Cell Biol & Regenerat, Tokyo, Japan
Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo, JapanJuntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
机构:
Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USAUniv Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
Jaquet, F
Goldstein, IB
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USAUniv Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
Goldstein, IB
Shapiro, D
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USAUniv Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA